| Initial visit | Randomization | RP | Post-RP follow-up | |||
---|---|---|---|---|---|---|---|
Eligibility | Intervention (baseline - V0) | V1 | V2 3 mo | V3 6 mo | V4 9 mo | V5 12 mo | |
Consent | Â | X | Â | Â | Â | Â | Â |
Medical history and health behaviors | Â | X | Â | Â | Â | Â | Â |
Concomitant medication/symptom evaluation | Â | X | Â | X | X | X | X |
Consultation with uro-oncologist | X | Â | Â | X* | X* | X* | X* |
Blood sample including total PSA and lipid profile | Â | X | X | X | X | X | X |
Digital rectal exam and urine sample | Â | X | Â | Â | Â | Â | Â |
Radical prostatectomy (RP) | Â | Â | X | Â | Â | Â | Â |
Food frequency questionnaire - FFQ online | Â | X | Â | Â | Â | Â | X |
Prostate specific quality of life (IPSS and EPIC-26) | Â | X | Â | X | X | X | X |
Hospital Anxiety and Depression Scale (HADS) | Â | X | Â | X | X | X | X |
Quality of life (sleep quality, fatigue, cognitive functioning) (ISI, ISF, FACT-COG V3) | Â | X | Â | X | X | X | X |
General health and wellbeing (SF-36) | Â | X | Â | X | X | X | X |
Fear of recurrence (FCRI) | Â | X | Â | X | X | X | X |
Self-reported sleep diary | Â | X | X | X | X | X | X |
Therapeutic expectation questionnaire | Â | Â | Â | X | Â | Â | X |
Anthropometric measurements¶ |  | X |  |  |  |  | X |
Vital signs£ |  | X |  | X | X | X | X |